Recommendations for Optimizing Tuberculosis Treatment: Therapeutic Drug Monitoring, Pharmacogenetics, and Nutritional Status Considerations
about
Arylamine N-acetyltransferase 2 genotype-dependent N-acetylation of isoniazid in cryopreserved human hepatocytes.Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care.Role of the N-acetylation polymorphism in solithromycin metabolism.The never-ending story of the fight against tuberculosis: from Koch's bacillus to global control programsVitamin D and the promoter methylation of its metabolic pathway genes in association with the risk and prognosis of tuberculosis
P2860
Recommendations for Optimizing Tuberculosis Treatment: Therapeutic Drug Monitoring, Pharmacogenetics, and Nutritional Status Considerations
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Recommendations for Optimizing ...... ritional Status Considerations
@ast
Recommendations for Optimizing ...... ritional Status Considerations
@en
Recommendations for Optimizing ...... ritional Status Considerations
@nl
type
label
Recommendations for Optimizing ...... ritional Status Considerations
@ast
Recommendations for Optimizing ...... ritional Status Considerations
@en
Recommendations for Optimizing ...... ritional Status Considerations
@nl
prefLabel
Recommendations for Optimizing ...... ritional Status Considerations
@ast
Recommendations for Optimizing ...... ritional Status Considerations
@en
Recommendations for Optimizing ...... ritional Status Considerations
@nl
P2093
P2860
P356
P1476
Recommendations for Optimizing ...... ritional Status Considerations
@en
P2093
Rihwa Choi
Soo Youn Lee
Won Jung Koh
P2860
P304
P356
10.3343/ALM.2017.37.2.97
P407
P5008
P577
2017-03-01T00:00:00Z